General Atlantic

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

9 Jan 2025

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

Verdiva Bio develops next-generation obesity and metabolic disease therapies, advancing oral and injectable treatment candidates to improve access, adherence and long-term outcomes.

General Atlantic

- Life Sciences
generalatlantic.com
Update Information

More venture news

LemonEdge
29 Jul 2026
LemonEdge announced £16m Series A round led by Blackstone Innovations Investments for a fund accounting platform built for private markets
Series AFintech
Humanoid
21 Jul 2026
Humanoid unlocks £114m Series A led by Prime Movers Lab to deploy humanoid robots across industrial manufacturing and logistics
Series AIndustrial
Arrakis
22 Jul 2026
Arrakis raises a £22m Series A led by Blossom Capital to install AI agents into industrial companies' mission-critical operations
Series AIndustrial

General Atlantic

Investment Portfolio

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

More venture news

LemonEdge announced £16m Series A round led by Blackstone Innovations Investments for a fund accounting platform built for private markets

Humanoid unlocks £114m Series A led by Prime Movers Lab to deploy humanoid robots across industrial manufacturing and logistics

Arrakis raises a £22m Series A led by Blossom Capital to install AI agents into industrial companies' mission-critical operations